PA GOODDOCTOR (01833) Reports Approximately RMB 3.725 Billion in Revenue for First Three Quarters, a Year-on-Year Increase of 13.6%, Continuing to Expand AI Technology to Enhance Healthcare Service Efficiency and Quality

Stock News
10/23

PA GOODDOCTOR (01833) has announced its financial results for the first three quarters, benefiting from the continuous deepening of its insurance-healthcare synergy model, the ongoing development of its insurance + healthcare membership model, and rapid advancement in corporate health management business. During this reporting period, the company achieved total revenue of RMB 3.725 billion, marking a 13.6% year-on-year increase; net profit reached RMB 184 million, up 72.6% year-on-year; and adjusted net profit amounted to RMB 216 million, representing a 45.7% year-on-year rise. Revenue from both F-end and B-end corporate health management businesses grew by 21.5% year-on-year. The F-end insurance synergy became increasingly refined, and product capabilities were continually enhanced. Additionally, in collaboration with China Ping An Insurance (Group) Company (Ping An Group), the company developed a product that integrates "commercial insurance + health protection service + healthcare services," accelerating the expansion into corporate clients and delivering a comprehensive, high-quality, and cost-effective health management service system for corporate employees. By the third quarter of 2025, the number of corporate clients served exceeded 4,500, and the number of paying B-end users increased by 30.6% year-on-year. The company collaborated with Ping An Group to gather traffic from both F-end and B-end corporate health services, integrating online and offline approaches, and fully empowering AI applications to refine a service model centered around clients, linking services at home, in-store, and on-site. Regarding family doctors, leveraging a family doctor team certified by Peking University International Hospital and the World Organization of Family Doctors, combined with AI services and a medical database, the company provided precise recommendations and proactive services, ensuring a high-quality service experience for users; as of the end of the reporting period, the family doctor membership rights covered over 40 million users. In terms of home-based elderly care, the company continues to explore a warm "insurance + home-based elderly care" service model, focusing on enhancing medical services, health management, emergency assistance, and remote care; by the end of the reporting period, the number of users benefiting from home-based elderly care services grew by 41% compared to the end of 2024. During the reporting period, the company has also deepened its AI capability development. Through the in-depth application of AI technology, the quality and efficiency of its professional medical services have been significantly improved, with the accuracy of complex disease MDT (Multidisciplinary Team) treatment plans rising to nearly 90% and helping reduce the average service cost per family doctor user by approximately 52% year-on-year. In the future, the company plans to continue expanding the application of AI technology across various complex diseases and business scenarios to enhance efficiency and quality in healthcare services.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10